Wang Bingxuan, Robertson Larry W, Wang Kai, Ludewig Gabriele
Human Toxicology, University of Iowa, Iowa City, USA.
Xenobiotica. 2011 Dec;41(12):1031-43. doi: 10.3109/00498254.2011.603763. Epub 2011 Oct 4.
CYP2S1 is an evolutionarily conserved, mainly extra-hepatic member of the CYP2 family and proposed to be regulated by the aryl hydrocarbon receptor (AhR). The present study explores AhR's regulation of CYP2S1 in male Sprague Dawley rats using PCB126 (3,3',4,4',5-pentachlorobiphenyl), the most potent AhR agonist among the PCBs. Additionally, CYP2S1 expression was examined after treatments with the classic CYP-inducers β-naphthoflavone (β-NF, AhR activator), phenobarbital (PB, CAR activator) and dexamethasone (Dex, PXR activator). CYP2S1 and CYP1A1/2, CYP1B1, CYP2B and CYP3A mRNAs were measured in liver, lung, spleen, stomach, kidney, and thymus at different time points. Constitutive CYP2S1 was expressed at comparable levels to other CYPs with the highest expression levels in stomach, kidney and lung. CYP2S1 mRNA was only non-significantly elevated by β-NF in liver tissues. PCB126 did not increase CYP2S1 mRNA in any organ and at any time point examined despite a significant induction of CYP1 genes. PCB126 reduced CYP2S1 mRNA by 40% (not significant) from the 7th post-exposure day in thymus. PB and Dex had no effect on CYP2S1 mRNA levels. These observations show that in this model CYP2S1 is not, or only weakly, regulated by AhR and not induced by CAR or PXR activators.
细胞色素P450 2S1(CYP2S1)是细胞色素P450 2(CYP2)家族中进化保守的、主要位于肝外的成员,据推测受芳烃受体(AhR)调控。本研究使用多氯联苯(PCB)中最有效的AhR激动剂多氯联苯126(3,3',4,4',5 - 五氯联苯),探讨AhR对雄性斯普拉格 - 道利大鼠CYP2S1的调控作用。此外,在用经典的CYP诱导剂β - 萘黄酮(β - NF,AhR激活剂)、苯巴比妥(PB,组成型雄烷受体激活剂)和地塞米松(Dex,孕烷X受体激活剂)处理后,检测了CYP2S1的表达。在不同时间点测量了肝脏、肺、脾脏、胃、肾脏和胸腺中CYP2S1以及CYP1A1/2、CYP1B1、CYP2B和CYP3A的mRNA水平。组成型CYP2S1的表达水平与其他细胞色素P450相当,在胃、肾脏和肺中的表达水平最高。在肝组织中,β - NF仅使CYP2S1 mRNA非显著升高。尽管CYP1基因有显著诱导,但在任何检测的器官和时间点,多氯联苯126均未增加CYP2S1 mRNA。从暴露后第7天起,多氯联苯126使胸腺中CYP2S1 mRNA降低了40%(不显著)。PB和Dex对CYP2S1 mRNA水平无影响。这些观察结果表明,在该模型中,CYP2S1不受AhR调控或仅受其微弱调控,且不受组成型雄烷受体或孕烷X受体激活剂诱导。